Noninvasive Brain Stimulation for Mild Cognitive Impairment

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

December 19, 2022

Study Completion Date

March 28, 2023

Conditions
Mild Cognitive ImpairmentMild Neurocognitive DisorderCognitive DeclineMental DeteriorationCognitive DysfunctionMemory DeclineMemory LossMemory Impairment
Interventions
DEVICE

Active rTMS (Bilateral DLPFC)

TMS Stimulation Parameters for the active DLPFC rTMS intervention group will be: 10 Hz, 4-second train duration and 11-second inter-train interval. During each session, 2,000 pulses will be applied for each hemisphere (for a total of 4,000 pulses per session). Participants will receive 20 sessions (1 or 2 sessions per day, M-F).

DEVICE

Active rTMS (Bilateral LPC)

TMS Stimulation Parameters for the active LPC rTMS intervention group will be: 10 Hz, 4-second train duration and 11-second inter-train interval. During each session, 2,000 pulses will be applied for each hemisphere (for a total of 4,000 pulses per session). Participants will receive 20 sessions (1 or 2 sessions per day, M-F).

DEVICE

Placebo rTMS (Inactive)

For the Placebo rTMS (Inactive) group, the participant will wear scalp electrodes through which a low voltage, low electric current (2-20mA at no more than 100V) is passed to mimic the sensation of receiving actual rTMS. Participants will receive 20 sessions (1 or 2 sessions per day, M-F).

Trial Locations (1)

94304

VA Palo Alto Health Care System, Palo Alto

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Palo Alto Veterans Institute for Research

OTHER

NCT03331796 - Noninvasive Brain Stimulation for Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter